Insider Transactions in Q4 2021 at Bio Atla, Inc. (BCAB)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,667
-0.35%
|
$88,673
$19.63 P/Share
|
|
Dec 31
2021
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
795
-0.87%
|
$15,105
$19.63 P/Share
|
|
Dec 31
2021
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,894
-0.84%
|
$54,986
$19.63 P/Share
|
|
Dec 31
2021
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.77%
|
$3,686
$19.63 P/Share
|
|
Dec 31
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,391
-1.03%
|
$26,429
$19.63 P/Share
|
|
Dec 02
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,811
-0.18%
|
$105,842
$22.11 P/Share
|
|
Dec 02
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
820
-0.44%
|
$18,040
$22.11 P/Share
|
|
Dec 02
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
2,984
-0.43%
|
$65,648
$22.11 P/Share
|
|
Dec 02
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
200
-0.39%
|
$4,400
$22.11 P/Share
|
|
Dec 02
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,434
-0.53%
|
$31,548
$22.11 P/Share
|
|
Dec 01
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,321
-0.6%
|
$559,383
$23.23 P/Share
|
|
Dec 01
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
173
-0.06%
|
$3,979
$23.23 P/Share
|
|
Dec 01
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
628
-0.06%
|
$14,444
$23.23 P/Share
|
|
Dec 01
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
1,011
-1.29%
|
$23,253
$23.23 P/Share
|
|
Dec 01
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,246
-1.71%
|
$166,658
$23.23 P/Share
|
|
Nov 30
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,490
-0.45%
|
$443,760
$24.69 P/Share
|
|
Nov 30
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
131
-0.05%
|
$3,144
$24.69 P/Share
|
|
Nov 30
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
478
-0.05%
|
$11,472
$24.69 P/Share
|
|
Nov 30
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
768
-0.95%
|
$18,432
$24.69 P/Share
|
|
Nov 30
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,510
-1.25%
|
$132,240
$24.69 P/Share
|
|
Nov 29
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,435
-1.12%
|
$355,005
$23.89 P/Share
|
|
Nov 29
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
110
-0.12%
|
$2,530
$23.89 P/Share
|
|
Nov 29
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
399
-0.11%
|
$9,177
$23.89 P/Share
|
|
Nov 29
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
642
-2.3%
|
$14,766
$23.89 P/Share
|
|
Nov 29
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,599
-3.0%
|
$105,777
$23.89 P/Share
|
|
Nov 24
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,022
-0.41%
|
$408,528
$24.94 P/Share
|
|
Nov 24
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
129
-0.05%
|
$3,096
$24.94 P/Share
|
|
Nov 24
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
466
-0.04%
|
$11,184
$24.94 P/Share
|
|
Nov 24
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
750
-0.88%
|
$18,000
$24.94 P/Share
|
|
Nov 24
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,937
-0.84%
|
$94,488
$24.94 P/Share
|
|
Nov 23
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,943
-0.88%
|
$623,575
$25.17 P/Share
|
|
Nov 23
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
187
-0.1%
|
$4,675
$25.17 P/Share
|
|
Nov 23
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
684
-0.1%
|
$17,100
$25.17 P/Share
|
|
Nov 23
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
1,100
-1.87%
|
$27,500
$25.17 P/Share
|
|
Nov 23
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,770
-1.79%
|
$144,250
$25.17 P/Share
|
|
Nov 22
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,675
-1.09%
|
$407,550
$26.23 P/Share
|
|
Nov 22
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
118
-0.13%
|
$3,068
$26.23 P/Share
|
|
Nov 22
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
430
-0.12%
|
$11,180
$26.23 P/Share
|
|
Nov 22
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
691
-2.27%
|
$17,966
$26.23 P/Share
|
|
Nov 22
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,626
-2.18%
|
$94,276
$26.23 P/Share
|
|
Nov 02
2021
|
Lawrence Steinman |
SELL
Open market or private sale
|
Direct |
450
-2.38%
|
$13,500
$30.0 P/Share
|
|
Oct 01
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
592
-0.63%
|
$17,760
$30.39 P/Share
|
|
Oct 01
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
2,994
-0.84%
|
$89,820
$30.18 P/Share
|